Interchange Capital Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$242K Buy
+627
New +$233K 0.05% 357
2021
Q1
Sell
-247
Closed -$79K 475
2020
Q4
$79K Buy
+247
New +$75.8K 0.04% 334

Other funds holding ELV

Interchange Capital Partners's ELV Position: Q2 2026 in Review

Interchange Capital Partners opened a new position in Elevance Health (ELV) in Q2 2026: 627 shares worth $242K. The stake represents 0.05% of the portfolio and ranks #357 among its holdings. This is a return to the name: Interchange Capital Partners previously reported a position in ELV as recently as Q4 2020.

Interchange Capital Partners first reported a position in ELV in Q4 2020 and has held it in 2 quarters since. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Interchange Capital Partners held 627 shares of Elevance Health worth $242K as of Q2 2026.
  • Elevance Health was a new Interchange Capital Partners position in Q2 2026.
  • Elevance Health made up 0.05% of Interchange Capital Partners's portfolio in Q2 2026, its #357 holding.
  • Interchange Capital Partners first reported a position in Elevance Health in Q4 2020 and has held it in 2 quarters since.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Interchange Capital Partners's 13F filing for Q2 2026, filed 20 Jul 2026.